All Type of News
Proper drug margin is essential for pharmaceutical industry
In a brief session with IFPMA Chairman Dr. Harvey E. Bale Jr., who visited the Korea Pharmaceutical Manufacturers Association on November 13, the association's chairman Kim Chung-soo and president Rhee Jang-han (chair...
Tylenol receives 2003 Brand Award
Janssen Korea's Tylenol was selected as one of 2003 brands in the local pharmaceutical sector on November 14, according to the recent survey of 253,000 customers that was conducted by the Korea Consumer Forum and the ...
Korean crude drugs to attract world's interests.
A 3-day world exhibition event for the pharmaceutical raw materials took place at Frankfurt in Germany from Oct. 27 to 29 under the title of "CPhI Worldwide 2003" where 13 Korean participants in the exhibition booths ...
30 companies to be denounced for illegal advertising.
Busan regional KFDA detected 30 companies on charge of false and exaggerate advertising for personal medical devices and denounced them to the relevant government authorities for appropriate administrative measures .
...
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be...
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be expired patent drugs
Many major pharmaceutical firms are scurrying to introduce the first generic versions of soon-to-be ex...
Dong-A Pharm Chairman accepts FKI's acting chiefKang Shin-ho, chairman of Dong-A Pharm, accepted an offer to serve as the acting chief of the Federation of Korean Industries during a meeting of its member companies' leaders o...
|
Wyeth Korea to launch pneumococcal conjugated vaccine PrevenarWyeth Korea announced on November 12 that Prevenar received marketing authorization from the Korea Food and Drug Administration.
The vaccine is the first and only pneumococc...
|
GSK's Zeffix slows liver cirrhotic progress.A sustained medication of GSK's Zeffix may significantly slow the progress of liver diseases complicated with a chronic "B" virus hepatitis, a researcher reported recently at th...
|
Green Cross Sang-A achieved 116% sales and 54% income.
Green Cross Sang-A has made a substantial jump in their sales and ordinary incomes during the 3rd quarter of this year according to the company official reports on Nov. 12.
The report describes that the company ach...
MR training booms in pharmaceutical circle
A number of employees at domestic pharmaceutical firms completed the medical representative (MR) training, which has been launched by the Korea Pharmaceutical Manufacturers Association in a bid to enhance the quality ...
